Primary biliary cholangitis: Personalizing second-line therapies

Primary Biliary Cholangitis: personalizing second-line therapies. #PBC is an enigmatic, #autoimmune disease targeting the small intralobular bile ducts resulting in cholestasis and potentially progression to biliary cirrhosis. https://t.co/IjoBG23L3J

Hepatology Primary Biliary Cholangitis: Personalizing Second-Line Therapies-R1 #PBC https://t.co/91wRXNUk3U